Is routine stress ulcer prophylaxis of benefit for patients undergoing cardiac surgery?

Interactive Cardiovascular and Thoracic Surgery

Volumn 14, Issue 5, 2012, Pages 622-627

  Shin, Jin Sup ^a   Abah, Udo ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Cardiac surgery; Gastric protection; Gastrointestinal haemorrhage; Pneumonia; Stress ulcer

Indexed keywords

ANTIHISTAMINIC AGENT; CIMETIDINE; CLOPIDOGREL; FAMOTIDINE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; TEPRENONE;

ARTICLE; DRUG EFFICACY; DRUG USE; HEART SURGERY; HEMATEMESIS; HEMATOLOGIC DISEASE; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; IMMUNE SYSTEM; INTUBATION; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PH; PRIORITY JOURNAL; PROPHYLAXIS; STOMACH ACID SECRETION; STRESS ULCER; UPPER GASTROINTESTINAL BLEEDING;

AGED; ANTI-ULCER AGENTS; BENCHMARKING; CARDIAC SURGICAL PROCEDURES; CROSS INFECTION; EVIDENCE-BASED MEDICINE; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; PNEUMONIA; PROTON PUMP INHIBITORS; RISK ASSESSMENT; RISK FACTORS; STOMACH ULCER; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 84863463068     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs019     Document Type: Article

References (11)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg 2003;2:405-9.
2. Hata M, Shiono M, Sekino H, Furukawa H, Sezai A, Iida M et al. Prospective randomized trial for optimal prophylactic treatment of the upper gastrointestinal complications after open heart surgery. Circ J 2005;69:331-4.
3. Gon S, Irie Y, Takahashi M. Effects of rabeprazole or famotidine during cardiac surgery on perioperative gastric and esophageal pH readings. Jpn J Thorac Cardiovasc Surg 2006;54:278-84.
4. Wagner BK, Amory DW, Majcher CM, DiFazio LT, Scott GE, Spotnitz AJ. Effects of intravenous famotidine on gastric acid secretion in patients undergoing cardiac surgery. Ann Pharmacother 1995;29: 349-53.
5. Tayama E, Hayashida N, Fukunaga S, Tayama K, Takaseya T, Hiratsuka R et al. High-dose cimetidine reduces proinflammatory reaction after cardiac surgery with cardiopulmonary bypass. Ann Thorac Surg 2001;72: 1945-9.
6. Rosen HR, Vlahakes GJ, Rattner DW. Fulminant peptic ulcer disease in cardiac surgical patients: pathogenesis, prevention, and management. Crit Care Med 1992;20:354-9.
7. Lamothe PH, Rao E, Serra AJ, Castellano J, Woronick CL, McNicholas KW et al. Comparative efficacy of cimetidine, famotidine, ranitidine, and mylanta in postoperative stress ulcers. Gastric pH control and ulcer prevention in patients undergoing coronary artery bypass graft surgery. Gastroenterology 1991;100:1515-20.
8. van der Voort PH, Zandstra DF. Pathogenesis, risk factors, and incidence of upper gastrointestinal bleeding after cardiac surgery: is specific prophylaxis in routine bypass procedures needed? J Cardiothorac Vasc Anesth 2000;14:293-9.
9. Eom CS, Jeon CY, Lim JW, Cho EG, Park SM, Lee KS. Use of acidsuppressive drugs and risk of pneumonia: a systematic review and meta-analysis. CMAJ 2011;183:310-9.
10. Harjai KJ, Shenoy C, Orshaw P, Usmani S, Boura J, Mehta RH. Clinical outcomes in patients with the concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention: an analysis from the Guthrie Health Off-Label Stent (GHOST) investigators. Circulation Cardiovasc Interv 2011;4:162-70.
11. Banerjee S, Weideman RA, Weideman MW, Little BB, Kelly KC, Gunter JT et al. Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention. Am J Cardiol 2011;107: 871-8.